Waging war on chronic inflammation

Halia Therapeutics CEO on moving into multiple Phase 2 trials for chronic inflammation and whether the company may have created a ‘longevity drug.’
Fresh from announcing positive Phase 1 trial results for its inflammation-targeting drug candidate, Utah-based biotech Halia Therapeutics is now pursuing Pha…Read More

Billionaire-backed Arena BioWorks has aging in its sights

New $500m privately funded institute integrates discovery and company creation as it aims to swiftly translate insights into therapeutics.
Arena BioWorks, a newly launched biomedical research institute, has set its sights on accelerating the translation of basic biological research into…Read More

‘A vaccine for aging in under ten years’

Agemica founder Ronjon Nag on the moonshot company he believes will develop a vaccine for aging and make a dramatic difference to lifespan and healthspan.
Agemica is on a mission to create a vaccine for aging; its platform uses an AI-driven approach to seek out antiaging therapies that address root cau…Read More

Reservoir Neuroscience set to restore health to the aging brain

Kizoo leads $4 million funding round to develop new therapies for neurodegenerative diseases.
Reservoir Neuroscience has announced the completion of a $4 million financing round to support its development of new therapies for neurodegenerative diseases. San Francisco=-based…Read More

Genflow launches two grant-funded longevity research programs

Longevity biotech collaborates with Revatis and EXO Biologics on new research into sarcopenia and SIRT6 MRNA delivery.
Longevity biotech Genflow Biosciences has teamed up with Revatis and EXO Biologics on two new longevity research programs, fueled by grants from the Government of…Read More